Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
BG Williams, LDW King, D Pulido, D Quinkert… - Nature …, 2024 - nature.com
Reticulocyte-binding protein homologue 5 (RH5), a leading blood-stage Plasmodium
falciparum malaria vaccine target, interacts with cysteine-rich protective antigen (CyRPA) …
falciparum malaria vaccine target, interacts with cysteine-rich protective antigen (CyRPA) …
A new landscape for malaria vaccine development
AJ Laurenson, MB Laurens - PLoS pathogens, 2024 - journals.plos.org
On October 6, 2021, the World Health Organization (WHO) recommended the first vaccine
against malaria to prevent Plasmodium falciparum malaria in children living in areas with …
against malaria to prevent Plasmodium falciparum malaria in children living in areas with …
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge
Malaria is a life-threatening disease of global health importance, particularly in sub-Saharan
Africa. The growth inhibition assay (GIA) is routinely used to evaluate, prioritize, and quantify …
Africa. The growth inhibition assay (GIA) is routinely used to evaluate, prioritize, and quantify …